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Mycoplasma pneumoniae and Chlamydophila pneumoniae have worldwide distribution and infect the 
upper and lower respiratory tract. Serology is still the most widely used method to diagnose both 
infections, even if its interpretation is difficult. 
OBJECTIVES 
M. and C. pneumoniae serology testing is currently carried out in our institute by microplate analyzer 
(ETIMax® 3000, DiaSorin), used together with Virion M. pneumoniae antibodies assays using native 
antigens, as well as with Medac total Chlamydia and C. pneumoniae antibodies assays. The 
objectives of this study are to evaluate Mycoplasma antibody kits using recombinant antigens, to 
improve specificity of results, and to review our current algorithm for Chlamydia serology. 
METHODS 
One hundred and fifteen sera were tested with M. pneumoniae antibody kits from Virion, Medac, 
Savyon and AniLabsystems. HA was used as reference method to confirm discordant results. Sixty-
one sera from 52 patients, including 15 with documented respiratory infection, were tested with C. 
pneumoniae IgA and IgG kits from Medac, Savyon and Euroimmun. MIF was used as reference 
method to confirm discordant results. 
RESULTS 
Agreement for at least 3 results or confirmation with HA established reliable diagnosis. Sensitivity was 
100%, 100%, 90% and 90% and specificity was 92%, 96%, 100% and 96% for M. pneumoniae IgM 
from Virion, Medac, Savyon, and AniLabsystems kits respectively. Medac and Savyon M. pneumoniae 
IgG kits discriminated healthy from sick patients better than did Virion kit; agreement between Medac 
and Savyon was 89.5%, 91.4% and 81.9% for IgM, IgA and IgG respectively. Sensitivity of Medac, 
Savyon and Euroimmun C. pneumoniae IgA was 92%, 100%, 59%; accuracy, using MIF as reference 
test, was 90%, 94% and 67% respectively. Agreement between Medac and Savyon was 93.1%. 
Sensitivity of Medac, Savyon and Euroimmun for C. pneumoniae IgG was 100%, 100% and 80%; 
accuracy was 97%, 87% and 77% respectively. 
CONCLUSION 
Savyon M. pneumoniae kits show less or no threshold results compared with the 3 other methods. The 
IgG assay discriminates sick from healthy patients well, with good correlation with the Medac kit. To 
facilitate interpretation of the results, we decided to perform C. pneumoniae Savyon IgA kit, well 
correlated with MIF, while Medac C. pneumoniae IgG kit was preferred because of better specificity 
and quantitative determination. 
 
